Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Epstein

Showing results (291-300 of 307) with videos related to

Pageof 31
Sort By:
Pediatrics|October 1, 1994
Caring for gravely ill childrenA R Fleischman, K Nolan, N N Dubler, et al.
The Journal of Biological Chemistry|April 9, 2014
Overexpression of smooth muscle myosin heavy chain leads to activation of the unfolded protein response and autophagic turnover of thick filament-associated proteins in vascular smooth muscle cellsCallie S Kwartler, Jiyuan Chen, Dhananjay Thakur, et al.
Pediatrics|January 1, 1987
Is chronic lung disease in low birth weight infants preventable? A survey of eight centersM E Avery, W H Tooley, J B Keller, et al.
Biomacromolecules|March 30, 2021
Metal-Free Polymer-Based Affinity Medium for Selective Purification of His6-Tagged ProteinsKeiichi Yoshimatsu, Krista R Fruehauf, Quanhong Zhu, et al.
Human Molecular Genetics|November 1, 1993
Myotonic dystrophy kinase is a component of neuromuscular junctionsP F van der Ven, G Jansen, T H van Kuppevelt, et al.
Archives of General Psychiatry|February 13, 2003
Screening for serious mental illness in the general populationRonald C Kessler, Peggy R Barker, Lisa J Colpe, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2007
N-(3-(phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: structure, synthesis and SARHolly L Deak, John R Newcomb, Joseph J Nunes, et al.
Bioorganic & Medicinal Chemistry|April 18, 2016
Purinylpyridinylamino-based DFG-in/αC-helix-out B-Raf inhibitors: Applying mutant versus wild-type B-Raf selectivity indices for compound profilingLongbin Liu, Matthew R Lee, Joseph L Kim, et al.
Bioorganic & Medicinal Chemistry|May 29, 2016
Corrigendum to "Purinylpyridinylamino-based DFG-in/αC-helix-out B-Raf inhibitors: Applying mutant versus wild-type B-Raf selectivity indices for compound profiling" [Bioorg. Med. Chem. 24 (2016) 2215-2234]Longbin Liu, Matthew R Lee, Joseph L Kim, et al.
Journal of Medicinal Chemistry|September 22, 2009
Selective inhibitors of the mutant B-Raf pathway: discovery of a potent and orally bioavailable aminoisoquinolineAdrian L Smith, Frenel F DeMorin, Nick A Paras, et al.
Pageof 31

Showing results (291-300 of 307) with videos related to

Sort By:
Pageof 31
Pediatrics|October 1, 1994
Caring for gravely ill childrenA R Fleischman, K Nolan, N N Dubler, et al.
The Journal of Biological Chemistry|April 9, 2014
Overexpression of smooth muscle myosin heavy chain leads to activation of the unfolded protein response and autophagic turnover of thick filament-associated proteins in vascular smooth muscle cellsCallie S Kwartler, Jiyuan Chen, Dhananjay Thakur, et al.
Pediatrics|January 1, 1987
Is chronic lung disease in low birth weight infants preventable? A survey of eight centersM E Avery, W H Tooley, J B Keller, et al.
Biomacromolecules|March 30, 2021
Metal-Free Polymer-Based Affinity Medium for Selective Purification of His6-Tagged ProteinsKeiichi Yoshimatsu, Krista R Fruehauf, Quanhong Zhu, et al.
Human Molecular Genetics|November 1, 1993
Myotonic dystrophy kinase is a component of neuromuscular junctionsP F van der Ven, G Jansen, T H van Kuppevelt, et al.
Archives of General Psychiatry|February 13, 2003
Screening for serious mental illness in the general populationRonald C Kessler, Peggy R Barker, Lisa J Colpe, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2007
N-(3-(phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: structure, synthesis and SARHolly L Deak, John R Newcomb, Joseph J Nunes, et al.
Bioorganic & Medicinal Chemistry|April 18, 2016
Purinylpyridinylamino-based DFG-in/αC-helix-out B-Raf inhibitors: Applying mutant versus wild-type B-Raf selectivity indices for compound profilingLongbin Liu, Matthew R Lee, Joseph L Kim, et al.
Bioorganic & Medicinal Chemistry|May 29, 2016
Corrigendum to "Purinylpyridinylamino-based DFG-in/αC-helix-out B-Raf inhibitors: Applying mutant versus wild-type B-Raf selectivity indices for compound profiling" [Bioorg. Med. Chem. 24 (2016) 2215-2234]Longbin Liu, Matthew R Lee, Joseph L Kim, et al.
Journal of Medicinal Chemistry|September 22, 2009
Selective inhibitors of the mutant B-Raf pathway: discovery of a potent and orally bioavailable aminoisoquinolineAdrian L Smith, Frenel F DeMorin, Nick A Paras, et al.
Pageof 31